Recombinant Human Anti-IL13 x Human Anti-IL4 Bispecific Antibody (scIgG) (SCIGG-H338)

Recombinant Anti-IL13 x Anti-IL4 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-IL13 and anti-IL4 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can block two proinﬂammatory cytokines simultaneously. It is designed for the research of Idiopathic pulmonary fibrosis therapy.

Datasheet INQUIRY

Specifications

Targets

IL13 & IL4

Type

Single chain IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Idiopathic pulmonary fibrosis

Targets

Target 1

IL13

Gene ID

3596

UniProt ID

P35225

Alternative Names

IL13; interleukin 13; P600; IL-13; interleukin-13

Target 2

IL4

Gene ID

3565

UniProt ID

D4HNR6

Alternative Names

IL4; interleukin 4; BSF1; IL-4; BCGF1; BSF-1; BCGF-1; interleukin-4; binetrakin; pitrakinra; B cell growth factor 1; interleukin 4 variant 2; B_cell stimulatory factor 1; lymphocyte stimulatory factor 1

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-IL13 x Human Anti-IL4 Bispecific Antibody (scIgG) (SCIGG-H338). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-IL13 x Human Anti-IL4 Bispecific Antibody (scIgG) (CAT#: SCIGG-H338)

Specifications

Targets

Customer Reviews and Q&As